The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy

The HIV-1 virus (human immunodeficiency virus) affects 36.9 million people worldwide, with approximately 900000 deaths in 2017. The virus carrier can develop severe immunodeficiency since CD4(+) T lymphocytes are the main target, leading to acquired immunodeficiency syndrome (AIDS). Despite advances...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanches-da-Silva, Gabriela De Nardi, Medeiros, Luiza Fonseca Sales, Lima, Fabio Mitsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721108/
https://www.ncbi.nlm.nih.gov/pubmed/31531340
http://dx.doi.org/10.1155/2019/8458263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721108/
https://www.ncbi.nlm.nih.gov/pubmed/31531340
http://dx.doi.org/10.1155/2019/8458263

Ejemplares similares